63539-189 : Ibrance 125 mg Oral Capsule


NDC63539-189
Labeler: U.S. Pharmaceuticals
Product Type: Human Prescription Drug
Drug Name:  Ibrance
Dosage Form: Oral Capsule
Application #: NDA207103
Rev. Date: 


Appearance:


Markings: PBC;125;Pfizer
Shapes:  Capsule
Colors:  Brown
Size (mm): 22
Segments: * 1

* Segments = the number of equally sized pieces which the pill can be broken into. In this case, a value of 1 indicates a solid pill with no score lines.

NDC Package Codes:

  • 63539-189-11: 21 CAPSULE IN 1 BOTTLE (63539‑189‑11)

Active Ingredients:

  • Palbociclib

Dosage Strength:

  • 125 mg

Inactive Ingredients:

  • Cellulose, Microcrystalline
  • Lactose Monohydrate
  • Sodium Starch Glycolate Type a Potato
  • Silicon Dioxide
  • Magnesium Stearate
  • Gelatin
  • Ferric Oxide Red
  • Ferric Oxide Yellow
  • Titanium Dioxide
  • Shellac
  • Ammonia
  • Propylene Glycol
  • Dimethicone

Pharmaceutical Classes:

  • Kinase Inhibitor [EPC]
  • Kinase Inhibitors [MoA]
  • Cytochrome P450 3A Inhibitors [MoA]

Related Products:

Based on records with the same trade name.
  • 63539-187 Ibrance 75 mg Oral Capsule by U.S. Pharmaceuticals
  • 63539-188 Ibrance 100 mg Oral Capsule by U.S. Pharmaceuticals
  • 0069-0187 Ibrance 75 mg Oral Capsule by Pfizer Laboratories Div Pfizer Inc
  • 0069-0188 Ibrance 100 mg Oral Capsule by Pfizer Laboratories Div Pfizer Inc
  • 0069-0189 Ibrance 125 mg Oral Capsule by Pfizer Laboratories Div Pfizer Inc

NDC QR Code

Scan the QR code below to easily reference this data in the future:

NDC 63539-189 QR Code

< Prev: 63539-188Next: 63539-197 >




Notice: The MedsChat® NDC Database compiles publicly available data from the FDA and the U.S. National Library of Medicine (NLM); The NLM is not responsible for the data presented and does not endorse or recommend this or any other product. While we make every effort to ensure that the information presented is accurate, you should assume that all results are unvalidated. To report any errors or inconsistencies please contact us.


Note: All times displayed are GMT - 7.

This information has been independently compiled and is for informational purposes only. It is not intended to be a substitute for medical advice from a qualified healthcare professional; nor is it intended to diagnose, treat, cure or prevent any disease. For more details please see the Medical Disclaimer. This page was last updated on 24 December 2015.

We are committed to your privacy.

Copyright © 2005-2019 All Rights Reserved. MedsChat® is a registered trademark of Limelight Innovations L.L.C. 9888 W Belleview Ave #5000, Denver, CO, 80123, USA